TRexBio, a pioneering discovery stage biotechnology company based in South San Francisco, has successfully raised an impressive $84 million in its latest funding round. Specializing in the intersection of computational biology and immunobiology, TRexBio is at the forefront of developing groundbreaking therapeutics aimed at tackling cancer and inflammatory diseases. This new capital will primarily be allocated towards advancing its innovative 'deep biology' discovery engine, which meticulously maps the behavior of T regulatory cells (Tregs) within human tissue as they relate to various disease processes. By integrating advanced computational tools with a keen focus on human biology, TRexBio is capable of identifying and characterizing novel therapeutic targets, paving the way for a robust portfolio of therapies designed to modulate the immune system effectively. The funds will also support the company’s ongoing research and development efforts, enabling it to enhance its pipeline of unique therapies that seek to restore immune homeostasis in affected patients. This funding marks a significant milestone in TRexBio's journey, empowering the team to accelerate its mission of revolutionizing treatment paradigms and ultimately improving patient outcomes in the realms of oncology and inflammatory diseases. As the biotechnology landscape continues to evolve, investments such as these underscore the critical importance of innovation-driven approaches to healthcare—a cornerstone of TRexBio's vision for the future.
TRexBio Secures $84 Million in Series B Funding to Advance Revolutionary Therapeutics for Cancer and Inflammatory Diseases
Recently funded · $84.0M Series bBiotechnology
Get the full TRexBio company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | NEW ID | Series b | $705.2K | today |
| 2 |  Arist United States | Series b | $14.1M | today |
| 3 |
